The Claim
Increased hepatic GPAM expression is associated with greater triglyceride accumulation in liver cells and reduced visceral fat storage in both human and mouse models.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Higher levels of GPAM protein in the liver correlate with more triglycerides stored in liver cells and less fat stored around internal organs in humans and mice.
See the scientific wording
Increased hepatic GPAM expression is associated with greater triglyceride accumulation in liver cells and reduced visceral fat storage in both human and mouse models, suggesting GPAM may act as a metabolic switch favoring hepatic over adipose lipid deposition.
When the liver produces more GPAM enzyme, it converts fatty acids into triglycerides more efficiently, trapping fat inside liver cells and leaving less fat available to be stored around internal organs.
What the research says
1 studyWhen the liver makes more of the GPAM enzyme, it stores more fat inside the liver and less fat around the organs—like a switch that directs fat to the liver instead of other parts of the body. This study showed that in mice and humans, more GPAM means more liver fat and less belly fat.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.